Two sample MR report


3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) levels against Rheumatoid arthritis || id:ebi-a-GCST90018910

Date: 08 November, 2026


Results from two sample MR:

method nsnp b se pval
MR Egger 3 -0.0465140 0.1757084 0.8352514
Weighted median 3 -0.1186725 0.0686797 0.0840039
Inverse variance weighted 3 -0.1301702 0.0651232 0.0456268
Simple mode 3 -0.1065686 0.0904694 0.3599952
Weighted mode 3 -0.1155067 0.0774622 0.2744259

Heterogeneity tests

method Q Q_df Q_pval
MR Egger 0.4267713 1 0.5135775
Inverse variance weighted 0.6895479 2 0.7083805

Test for directional horizontal pleiotropy

egger_intercept se pval
-0.0214296 0.0418043 0.6984393

Test that the exposure is upstream of the outcome

snp_r2.exposure snp_r2.outcome correct_causal_direction steiger_pval
0.0004444 0 TRUE 0.0582658

Note - R^2 values are approximate


Forest plot of single SNP MR

plot of chunk chunk5


Comparison of results using different MR methods

plot of chunk chunk6


Funnel plot

plot of chunk chunk7


Leave-one-out sensitivity analysis

plot of chunk chunk8